Clark Capital Management Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $510K | Buy |
1,449
+122
| +9% | +$43.5K | ﹤0.01% | 384 |
|
|
2025
Q4 | $434K | Buy |
1,327
+224
| +20% | +$71.1K | ﹤0.01% | 375 |
|
|
2025
Q3 | $311K | Buy |
1,103
+182
| +20% | +$52.8K | ﹤0.01% | 389 |
|
|
2025
Q2 | $257K | Sell |
921
-87
| -9% | -$24.6K | ﹤0.01% | 387 |
|
|
2025
Q1 | $314K | Sell |
1,008
-255
| -20% | -$75.3K | ﹤0.01% | 375 |
|
|
2024
Q4 | $329K | Sell |
1,263
-121,340
| -99% | -$36M | ﹤0.01% | 364 |
|
|
2024
Q3 | $39.5M | Buy |
122,603
+2,362
| +2% | +$773K | 0.27% | 114 |
|
|
2024
Q2 | $37.6M | Buy |
120,241
+1,838
| +2% | +$540K | 0.28% | 113 |
|
|
2024
Q1 | $33.7M | Sell |
118,403
-90,535
| -43% | -$26.5M | 0.25% | 130 |
|
|
2023
Q4 | $60.2M | Buy |
+208,938
| New | +$56.9M | 0.49% | 54 |
|
|
2020
Q4 | – | Sell |
-71,755
| Closed | -$18.2M | – | 341 |
|
|
2020
Q3 | $18.2M | Sell |
71,755
-3,395
| -5% | -$841K | 0.34% | 123 |
|
|
2020
Q2 | $17.7M | Sell |
75,150
-1,224
| -2% | -$279K | 0.33% | 122 |
|
|
2020
Q1 | $15.5M | Sell |
76,374
-28,524
| -27% | -$6.23M | 0.39% | 104 |
|
|
2019
Q4 | $25.3M | Sell |
104,898
-2,073
| -2% | -$457K | 0.53% | 64 |
|
|
2019
Q3 | $20.7M | Buy |
106,971
+881
| +0.8% | +$169K | 0.47% | 87 |
|
|
2019
Q2 | $19.6M | Buy |
106,090
+6,764
| +7% | +$1.21M | 0.41% | 92 |
|
|
2019
Q1 | $18.9M | Sell |
99,326
-78,721
| -44% | -$15M | 0.45% | 91 |
|
|
2018
Q4 | $34.7M | Sell |
178,047
-40,277
| -18% | -$7.86M | 0.93% | 33 |
|
|
2018
Q3 | $45.3M | Buy |
218,324
+43,901
| +25% | +$8.65M | 1.15% | 20 |
|
|
2018
Q2 | $32.2M | Buy |
174,423
+12,674
| +8% | +$2.24M | 0.93% | 32 |
|
|
2018
Q1 | $27.6M | Buy |
161,749
+45,642
| +39% | +$8.38M | 0.86% | 36 |
|
|
2017
Q4 | $20.2M | Sell |
116,107
-24,621
| -17% | -$4.36M | 0.62% | 60 |
|
|
2017
Q3 | $26.2M | Buy |
140,728
+36,865
| +35% | +$6.53M | 0.88% | 31 |
|
|
2017
Q2 | $17.9M | Buy |
103,863
+11,192
| +12% | +$1.82M | 0.7% | 41 |
|
|
2017
Q1 | $15.2M | Sell |
92,671
-63,821
| -41% | -$10.6M | 0.67% | 47 |
|
|
2016
Q4 | $22.9M | Buy |
156,492
+19,831
| +15% | +$2.98M | 1.19% | 14 |
|
|
2016
Q3 | $22.8M | Buy |
136,661
+12,399
| +10% | +$2.1M | 1.31% | 10 |
|
|
2016
Q2 | $18.9M | Buy |
124,262
+22,286
| +22% | +$3.46M | 1.22% | 13 |
|
|
2016
Q1 | $15.3M | Buy |
101,976
+40,718
| +66% | +$6.05M | 1.18% | 20 |
|
|
2015
Q4 | $9.94M | Buy |
61,258
+5,801
| +10% | +$912K | 0.81% | 34 |
|
|
2015
Q3 | $7.67M | Sell |
55,457
-10,034
| -15% | -$1.58M | 0.68% | 47 |
|
|
2015
Q2 | $10.1M | Buy |
65,491
+1,019
| +2% | +$163K | 0.92% | 30 |
|
|
2015
Q1 | $10.3M | Buy |
64,472
+5,636
| +10% | +$888K | 0.94% | 29 |
|
|
2014
Q4 | $9.37M | Buy |
58,836
+4,196
| +8% | +$654K | 0.86% | 33 |
|
|
2014
Q3 | $7.67M | Buy |
54,640
+2,223
| +4% | +$290K | 0.66% | 38 |
|
|
2014
Q2 | $6.21M | Sell |
52,417
-3,436
| -6% | -$398K | 0.52% | 56 |
|
|
2014
Q1 | $6.89M | Buy |
55,853
+43,920
| +368% | +$5.33M | 0.59% | 49 |
|
|
2013
Q4 | $1.36M | Sell |
11,933
-580
| -5% | -$66K | 0.11% | 123 |
|
|
2013
Q3 | $1.4M | Sell |
12,513
-7,101
| -36% | -$770K | 0.11% | 121 |
|
|
2013
Q2 | $1.94M | Buy |
+19,614
| New | +$2.04M | 0.18% | 98 |
|
Other funds holding AMGN
VCM
VPM
Clark Capital Management Group's AMGN Position: Q1 2026 in Review
Clark Capital Management Group increased its Amgen (AMGN) stake by 9.2% in Q1 2026, buying an estimated $43.5K and bringing the position to 1,449 shares worth $510K. The position accounts for ﹤0.01% of the portfolio, ranked #384.
Clark Capital Management Group first reported a position in AMGN in Q2 2013 and has held it in 40 quarters since. The position peaked at $60.2M in Q4 2023. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Clark Capital Management Group held 1,449 shares of Amgen worth $510K as of Q1 2026.
- Clark Capital Management Group bought 122 Amgen shares in Q1 2026, an estimated $43.5K.
- Amgen made up ﹤0.01% of Clark Capital Management Group's portfolio in Q1 2026, its #384 holding.
- Clark Capital Management Group first reported a position in Amgen in Q2 2013 and has held it in 40 quarters since.
- Clark Capital Management Group's Amgen position peaked at $60.2M in Q4 2023.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Clark Capital Management Group's 13F filing for Q1 2026, filed 15 May 2026.